Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
- PMID: 11259830
- DOI: 10.1016/s0169-409x(00)00129-0
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Abstract
Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described. In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the molecular weight (MWT) is greater than 500 and the calculated Log P (CLogP) is greater than 5 (or MlogP > 4.15). Computational methodology for the rule-based Moriguchi Log P (MLogP) calculation is described. Turbidimetric solubility measurement is described and applied to known drugs. High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric solubility than leads in the pre-HTS era. In the development setting, solubility calculations focus on exact value prediction and are difficult because of polymorphism. Recent work on linear free energy relationships and Log P approaches are critically reviewed. Useful predictions are possible in closely related analog series when coupled with experimental thermodynamic solubility measurements.
Similar articles
-
High throughput solubility measurement in drug discovery and development.Adv Drug Deliv Rev. 2007 Jul 30;59(7):546-67. doi: 10.1016/j.addr.2007.05.007. Epub 2007 May 29. Adv Drug Deliv Rev. 2007. PMID: 17604872 Review.
-
Physicochemical profiling (solubility, permeability and charge state).Curr Top Med Chem. 2001 Sep;1(4):277-351. doi: 10.2174/1568026013395100. Curr Top Med Chem. 2001. PMID: 11899112 Review.
-
Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.Mol Pharm. 2016 May 2;13(5):1564-74. doi: 10.1021/acs.molpharmaceut.6b00044. Epub 2016 Apr 13. Mol Pharm. 2016. PMID: 27031624
-
Prediction of drug solubility from structure.Adv Drug Deliv Rev. 2002 Mar 31;54(3):355-66. doi: 10.1016/s0169-409x(02)00008-x. Adv Drug Deliv Rev. 2002. PMID: 11922952 Review.
-
Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data.J Med Chem. 2020 Sep 24;63(18):10091-10108. doi: 10.1021/acs.jmedchem.9b01596. Epub 2020 May 11. J Med Chem. 2020. PMID: 32324397
Cited by
-
Jatropha Diterpenes: An Updated Review Concerning Their Structural Diversity, Therapeutic Performance, and Future Pharmaceutical Applications.Pharmaceuticals (Basel). 2024 Oct 19;17(10):1399. doi: 10.3390/ph17101399. Pharmaceuticals (Basel). 2024. PMID: 39459038 Free PMC article. Review.
-
Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation.PeerJ. 2021 Apr 13;9:e11261. doi: 10.7717/peerj.11261. eCollection 2021. PeerJ. 2021. PMID: 33954055 Free PMC article.
-
Estimation of drug-likeness properties of GC-MS separated bioactive compounds in rare medicinal Pleione maculata using molecular docking technique and SwissADME in silico tools.Netw Model Anal Health Inform Bioinform. 2021;10(1):14. doi: 10.1007/s13721-020-00276-1. Epub 2021 Feb 24. Netw Model Anal Health Inform Bioinform. 2021. PMID: 33643765 Free PMC article.
-
Network pharmacological identification of active compounds and potential actions of Erxian decoction in alleviating menopause-related symptoms.Chin Med. 2015 Jul 19;10:19. doi: 10.1186/s13020-015-0051-z. eCollection 2015. Chin Med. 2015. PMID: 26191080 Free PMC article.
-
Discovery, synthesis and structure-activity analysis of symmetrical 2,7-disubstituted fluorenones as urea transporter inhibitors.Medchemcomm. 2015;6:1278-1284. doi: 10.1039/C5MD00198F. Medchemcomm. 2015. PMID: 26191399 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
